Cevik M, Thompson LC, Upton C, Rolla VC, et al. Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial. Lancet Infect Dis 2024 May 17:S1473-3099(24)00223.
PMID: 38768617